In a report released on April 29, Andrew Berens from Leerink Partners maintained a Buy rating on AstraZeneca (AZN – Research Report), ...
European pharma giant AstraZeneca Plc’s (NASDAQ:AZN) Covid vaccine, developed with the University of Oxford, is facing a class action lawsuit alleging its vaccine caused death and serious injury ...
The stock has soared 110% in the last 10 years, driven by its triumphs in medical science. Valued at $235 billion by market cap, AZN stock is up 12.2% year-to-date, compared to the S&P 500’s ($SPX) ...
In top news on UK stocks, AstraZeneca PLC (GB:AZN) shares are rising today after the company released promising updates on ...
D AZN, the global sports streaming service, has acquired rights to motor racing’s Formula 1 (F1) series in Portugal for the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Covid vaccine, developed with the University of Oxford, is facing a class action lawsuit alleging its vaccine caused death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback